Total
|
n = 54
|
n = 25
|
n = 7
|
Abdomena
|
54 (100)
|
16 (64)
|
7 (100)
|
Liver disease assessment, n (%)
|
48 (89)
|
2 (13)
|
4 (57)
|
Splenomegaly, n (%)
|
48 (89)
|
2 (13)
|
6 (86)
|
Pancreas assessment, n (%)
|
38 (70)
|
4 (25)
|
4 (57)
|
Cholecystolithiasis, n (%)
|
49 (91)
|
4 (25)
|
7 (100)
|
Cholecystitis, n (%)
|
46 (85)
|
6 (38)
|
6 (86)
|
Obstructive jaundice, n (%)
|
42 (78)
|
6 (38)
|
4 (57)
|
Free fluid in the abdomen, n (%)
|
50 (93)
|
4 (25)
|
7 (100)
|
Renal colic, n (%)
|
44 (81)
|
5 (31)
|
5 (71)
|
Kidney congestion, n (%)
|
50 (93)
|
4 (25)
|
5 (71)
|
Appendicitis, n (%)
|
36 (67)
|
6 (38)
|
3 (43)
|
Diverticulitis, n (%)
|
30 (56)
|
5 (31)
|
4 (57)
|
Hernia, n (%)
|
24 (44)
|
6 (38)
|
2 (29)
|
Abdominal aortic aneurysm, n (%)
|
42 (78)
|
6 (38)
|
5 (71)
|
Abdominal trauma, n (%)
|
33 (61)
|
2 (13)
|
5 (71)
|
Irritable bowel disease, n (%)
|
18 (33)
|
4 (25)
|
2 (29)
|
Bladder diseases, n (%)
|
37 (69)
|
4 (25)
|
5 (71)
|
Bladder filling condition, n (%)
|
49 (91)
|
2 (13)
|
7 (100)
|
Evaluation of the prostate, n (%)
|
40 (74)
|
3 (19)
|
4 (57)
|
Testicular torsion, n (%)
|
16 (30)
|
4 (25)
|
1 (14)
|
Testicular pain, n (%)
|
24 (44)
|
3 (19)
|
1 (14)
|
Testicular inflammation, n (%)
|
20 (37)
|
3 (19)
|
1 (14)
|
Cardiaca
|
34 (63)
|
11 (44)
|
6 (86)
|
Pericardial effusion, n (%)
|
33 (97)
|
4 (36)
|
6 (100)
|
Evaluation of ventricular size and function, n (%)
|
4 (12)
|
8 (73)
|
1 (17)
|
Undifferentiated hypotension, n (%)
|
6 (18)
|
6 (55)
|
–
|
Valvular assessment, n (%)
|
2 (6)
|
5 (45)
|
1 (17)
|
Vasculara
|
32 (59)
|
13 (52)
|
1 (14)
|
Deep venous thrombosis, n (%)
|
28 (88)
|
8 (62)
|
1 (100)
|
Intima-media thickness / Carotid plaque, n (%)
|
17 (53)
|
4 (31)
|
–
|
Jugular venous distention, n (%)
|
5 (16)
|
4 (31)
|
1 (100)
|
Thoracica
|
45 (83)
|
15 (60)
|
6 (86)
|
Pneumothorax, n (%)
|
19 (42)
|
10 (67)
|
3 (50)
|
Pleural effusion, n (%)
|
42 (93)
|
5 (33)
|
4 (67)
|
Ribs fractures, n (%)
|
25 (56)
|
10 (67)
|
5 (83)
|
Chest painORShortness of breathORDyspnea, n (%)
|
11 (24)
|
5 (33)
|
1 (17)
|
Auscultatory Changes in the lungs, n (%)
|
9 (20)
|
7 (47)
|
1 (17)
|
Chest trauma, n (%)
|
14 (31)
|
6 (40)
|
3 (50)
|
Women’s Reproductive Healtha
|
14 (26)
|
3 (12)
|
–
|
Ovarian pathology, n (%)
|
12 (86)
|
3 (100)
|
–
|
First term pregnancy, n (%)
|
5 (36)
|
2 (67)
|
–
|
Ruptured ectopic pregnancy, n (%)
|
3 (21)
|
2 (67)
|
–
|
Abnormal vaginal Bleeding, n (%)
|
6 (43)
|
2 (67)
|
–
|
Uterine ultrasoundORuterine mass assessment, n (%)
|
11 (79)
|
2 (67)
|
–
|
Musculoskeletal & Other conditionsa
|
43 (80)
|
17 (68)
|
3 (43)
|
Fracture, n (%)
|
12 (28)
|
8 (47)
|
2 (67)
|
Joint effusion, tendon or ligament rupture, n (%)
|
21 (49)
|
6 (35)
|
3 (100)
|
Joint assessment and muscular injuries, n (%)
|
16 (37)
|
5 (29)
|
–
|
Evaluation of rheumatoid arthritis, n (%)
|
4 (9)
|
3 (18)
|
1 (33)
|
ThyroidORParathyroid, n (%)
|
31 (72)
|
9 (53)
|
1 (33)
|
Adrenal screening, n (%)
|
8 (19)
|
4 (24)
|
–
|
Evaluation of lymph nodesORPalpable neck mass, n (%)
|
33 (77)
|
5 (29)
|
–
|
Abscesses and cysts, n (%)
|
38 (88)
|
4 (24)
|
2 (67)
|
US for guided procedures, n (%)
|
14 (33)
|
–
|
–
|
US for pain management, n (%)
|
4 (9)
|
–
|
–
|